ACTRN12606000444583尚未招募1 期
Preliminary study on submucosous sclerosis of pharyngx with 1% polidocanol to treat obstructive sleep apnea (OSA) & snoring subjects (SS)
Youliang Yin0 个研究点目标入组 30 人开始时间: 2006年10月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •OSAS & ,SS which palatopharyngeal collapse.
排除标准
- •Obstructive sleep apnea syndrom (OSAS) & snoring subjects (SS),which anatomic narrow result.
研究者
相似试验
Unknown
1 期
Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)ApneaSnoringNCT00399451Liaoyang Central Hospital30
进行中（未招募）
不适用
The effect of submucosal fibrosis on endoscopic submucosal dissection of colorectal tumorsKCT0001020Konkuk University Medical Center170
已完成
不适用
Analysis of submucosal (SM) invasion site of laterally spreading tumor among subtypeslaterally spreading tumor (LST) (early colorectal cancer or adenoma)JPRN-UMIN000020261Showa University Northern Yokohama Hospital150
已完成
2 期
Phase II study on reduction of mucous membrane inflammation by the nutritional supplement Elental in concurrent chemoradiotherapy for head and neck squamous cell carcinomaHead and neck cancerJPRN-UMIN000010370iigata University, Faculty of Medicine50
进行中（未招募）
1 期
Systemic sclerosis associated interstitial lung disease: A longitudinal observational study assessing optimum treatment regimens. - Assessment of scleroderma lung diseaseSystemic Sclerosis associated interstitial lung diseaseMedDRA version: 9.1Level: LLTClassification code 10042953Term: Systemic sclerosisEUCTR2008-000224-27-GBewcastle upon Tyne NHS Foundation Trust20